Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01820494 · ClinicalTrials.gov registry record · NA
Nutritional Management of Infants With Chronic Diarrhea
A NA study of Growth and Tolerance Infant Study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 3
- Study locations
NCT01820494: Completed NA study of Growth and Tolerance Infant Study, sponsored by Abbott Nutrition.
NCT01820494 is a NA study of Growth and Tolerance Infant Study that has completed, run by Abbott Nutrition. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01820494, a NA study of Growth and Tolerance Infant Study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study objective is to assess the growth of infants fed an experimental formula for the nutritional management of chronic diarrhea.
Primary Outcome
Change in weight from baseline.
Conditions Studied
Interventions
- OTHER Experimental Infant Formula
Study Locations (3)
Maryland
- Johns Hopkins Hospital - Baltimore
Michigan
- Children's Hospital of Detroit - Detroit
Nebraska
- Children's Hospital - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2000-10 |
| Est. Completion | 2002-11 |
| Phase | NA |
What the finished NCT01820494 record still lists
NCT01820494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Growth and Tolerance Infant Study appearing as the primary indexed condition, and to 1 intervention - of which Experimental Infant Formula is the first listed.
NCT01820494 reports a single indexed study location in Maryland, Michigan, Nebraska.
Frequently Asked Questions
What is clinical trial NCT01820494 about?
NCT01820494 is a clinical study titled "Nutritional Management of Infants With Chronic Diarrhea". The study objective is to assess the growth of infants fed an experimental formula for the nutritional management of chronic diarrhea.
What is the current status of trial NCT01820494?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2000-10. Estimated completion is 2002-11.
What conditions does trial NCT01820494 study?
This clinical trial studies the following conditions: Growth and Tolerance Infant Study.
What interventions are being tested in trial NCT01820494?
The interventions under investigation include: Experimental Infant Formula (OTHER).
Who is sponsoring clinical trial NCT01820494?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01820494 being conducted?
This trial has 3 study locations across Maryland, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01820494's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia